Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-050166

Chief Executive Officer sold 4,400 shares at an average $13.54 ($59,554)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-08-22 Sale −2,200 $13.56 $29,832 443,978 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-08-23 Sale −2,200 $13.51 $29,722 441,778 I: show line 2 in the form
Open-market sales · 4,400 sh · avg $13.54 · $59,554
Loading xslF345X03/doc4.xml…